Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART27.13

NEXT STORY
CrownBio und NEXT Oncology geben strategische PDX-Modellpartnerschaft bekannt
PREV STORY
The global biopsy devices market was valued at $2,728 million in 2018 and is expected to reach $4,310 million by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Eight New ROSA Robots Sold in Fiscal Q2 2016

MONTPELLIER, France, Jan. 05, 2016 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a ...

author_avatar
NASDAQ Market News

BioTelemetry, Inc. to Release First Quarter 2017 Earnings Results on May 3, 2017

MALVERN, Pa., April 25, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its ...

author_avatar
NASDAQ Market News

ALX Oncology Announces Initial Data from ASPEN-02, the Ongoing Phase 1 / 2 Study of Evorpacept in Combination with Azacitidine, Demonstrating Safety and Preliminary Activity in Patients with Myelodysplastic Syndrome

author_avatar
NASDAQ Market News